205 related articles for article (PubMed ID: 33647319)
1. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
[TBL] [Abstract][Full Text] [Related]
2. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.
Malaviya R; Sunil VR; Venosa A; Verissimo VL; Cervelli JA; Vayas KN; Hall L; Laskin JD; Laskin DL
Toxicol Sci; 2015 Nov; 148(1):71-88. PubMed ID: 26243812
[TBL] [Abstract][Full Text] [Related]
4. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard-Induced Lung Injury and Fibrosis.
Venosa A; Malaviya R; Choi H; Gow AJ; Laskin JD; Laskin DL
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):436-46. PubMed ID: 26273949
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
[TBL] [Abstract][Full Text] [Related]
7. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
8. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.
Ma JY; Barger MW; Hubbs AF; Castranova V; Weber SL; Ma JK
J Toxicol Environ Health A; 1999 Jun; 57(4):247-66. PubMed ID: 10406349
[TBL] [Abstract][Full Text] [Related]
9. Protective and anti-inflammatory effect of selenium nano-particles against bleomycin-induced pulmonary injury in male rats.
Shahabi R; Anissian A; Javadmoosavi SA; Nasirinezhad F
Drug Chem Toxicol; 2021 Jan; 44(1):92-100. PubMed ID: 31146593
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.
Lei Y; Wang K; Li X; Li Y; Feng X; Zhou J; Zhang Z; Huang C; Zhang T
Clin Sci (Lond); 2019 Apr; 133(7):789-804. PubMed ID: 30902828
[TBL] [Abstract][Full Text] [Related]
11. Lung injury, oxidative stress and fibrosis in mice following exposure to nitrogen mustard.
Sunil VR; Vayas KN; Abramova EV; Rancourt R; Cervelli JA; Malaviya R; Goedken M; Venosa A; Gow AJ; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2020 Jan; 387():114798. PubMed ID: 31678244
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Guo ZZ; Sun HY; Hu DC; Yang GH; Li YM; Wei LQ
PLoS One; 2013; 8(11):e81090. PubMed ID: 24260540
[TBL] [Abstract][Full Text] [Related]
14. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
15. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis.
Di Paola R; Talero E; Galuppo M; Mazzon E; Bramanti P; Motilva V; Cuzzocrea S
Respir Res; 2011 Apr; 12(1):41. PubMed ID: 21477302
[TBL] [Abstract][Full Text] [Related]
17. Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release.
Chen B; Jiang L; Zhao W; Yu R; Hou XM
Respirology; 1997 Jun; 2(2):151-5. PubMed ID: 9441129
[TBL] [Abstract][Full Text] [Related]
18. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
Kseibati MO; Sharawy MH; Salem HA
Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
